Free tool
Medicare drug spending
Last checked: Nov 19, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
15
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 15 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Slynd Drospirenone | D | $2.0M | +5% | 1,718 | $1,138 | $6.86 |
| Drospirenone-Ethinyl Estradiol Ethinyl Estradiol/Drospirenone | D | $571K | -23% | 3,910 | $146 | $0.66 |
| Angeliq Drospirenone/Estradiol | D | $404K | -5% | 299 | $1,351 | $6.51 |
| Loryna Ethinyl Estradiol/Drospirenone | D | $176K | -16% | 1,321 | $133 | $0.68 |
| Nikki Ethinyl Estradiol/Drospirenone | D | $129K | -25% | 1,045 | $124 | $0.65 |
| Syeda Ethinyl Estradiol/Drospirenone | D | $114K | -24% | 705 | $161 | $0.71 |
| Yaz Ethinyl Estradiol/Drospirenone | D | $101K | -11% | 70 | $1,447 | $5.89 |
| Nextstellis Drospirenone/Estetrol | D | $94K | +20% | 81 | $1,159 | $7.20 |
| Lo-Zumandimine Ethinyl Estradiol/Drospirenone | D | $73K | +10% | 658 | $110 | $0.67 |
| Vestura Ethinyl Estradiol/Drospirenone | D | $51K | -28% | 441 | $115 | $0.54 |
| Drospirenone-Eth Estra-Levomef Drospir/Eth Estra/Levomefol Ca | D | $49K | -7% | 77 | $636 | $3.02 |
| Yasmin 28 Ethinyl Estradiol/Drospirenone | D | $44K | -15% | 40 | $1,095 | $4.60 |
| Ocella Ethinyl Estradiol/Drospirenone | D | $13K | -55% | 97 | $130 | $0.64 |
| Zumandimine Ethinyl Estradiol/Drospirenone | D | $8K | +0% | 94 | $89 | $0.59 |
| Jasmiel Ethinyl Estradiol/Drospirenone | D | $6K | -33% | 71 | $78 | $0.62 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.